SE0401539D0 - New compounds - Google Patents

New compounds

Info

Publication number
SE0401539D0
SE0401539D0 SE0401539A SE0401539A SE0401539D0 SE 0401539 D0 SE0401539 D0 SE 0401539D0 SE 0401539 A SE0401539 A SE 0401539A SE 0401539 A SE0401539 A SE 0401539A SE 0401539 D0 SE0401539 D0 SE 0401539D0
Authority
SE
Sweden
Prior art keywords
new compounds
arrhythmias
prophylaxis
useful
formula
Prior art date
Application number
SE0401539A
Other languages
English (en)
Swedish (sv)
Inventor
Peter Bonn
Johan Kajanus
Fritiof Ponten
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32710059&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE0401539(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0401539A priority Critical patent/SE0401539D0/xx
Publication of SE0401539D0 publication Critical patent/SE0401539D0/xx
Priority to TW094118682A priority patent/TW200612907A/zh
Priority to CN200910134138A priority patent/CN101525339A/zh
Priority to MXPA06014692A priority patent/MXPA06014692A/es
Priority to SG200904004-9A priority patent/SG153822A1/en
Priority to KR1020077000930A priority patent/KR20070039045A/ko
Priority to US11/570,451 priority patent/US7648985B2/en
Priority to RU2006145202/04A priority patent/RU2379311C9/ru
Priority to AU2005254924A priority patent/AU2005254924B2/en
Priority to PCT/SE2005/000891 priority patent/WO2005123748A1/fr
Priority to BRPI0512012-8A priority patent/BRPI0512012A/pt
Priority to EP05752679.0A priority patent/EP1765832B8/fr
Priority to DK05752679.0T priority patent/DK1765832T3/da
Priority to CA002568895A priority patent/CA2568895A1/fr
Priority to CNA200580019259XA priority patent/CN1968956A/zh
Priority to ES05752679T priority patent/ES2434043T3/es
Priority to UAA200612695A priority patent/UA85877C2/uk
Priority to JP2007516430A priority patent/JP2008502678A/ja
Priority to UY28959A priority patent/UY28959A1/es
Priority to ARP050102431A priority patent/AR049823A1/es
Priority to IL179560A priority patent/IL179560A0/en
Priority to ZA200610418A priority patent/ZA200610418B/en
Priority to NO20070148A priority patent/NO20070148L/no
Priority to ZA200710111A priority patent/ZA200710111B/xx
Priority to US12/497,792 priority patent/US20090270383A1/en
Priority to AU2009222548A priority patent/AU2009222548A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
SE0401539A 2004-06-15 2004-06-15 New compounds SE0401539D0 (sv)

Priority Applications (26)

Application Number Priority Date Filing Date Title
SE0401539A SE0401539D0 (sv) 2004-06-15 2004-06-15 New compounds
TW094118682A TW200612907A (en) 2004-06-15 2005-06-07 New compounds
UAA200612695A UA85877C2 (uk) 2004-06-15 2005-06-13 Оксабіспідинові сполуки та їх застосування у лікуванні серцевих аритмій
JP2007516430A JP2008502678A (ja) 2004-06-15 2005-06-13 新規オキサビスピジン化合物及び不整脈の治療におけるそれらの使用
EP05752679.0A EP1765832B8 (fr) 2004-06-15 2005-06-13 Nouveaux composes oxabispidine et leur utilisation dans le traitement des arythmies cardiaques
CA002568895A CA2568895A1 (fr) 2004-06-15 2005-06-13 Nouveaux composes oxabispidine et leur utilisation dans le traitement des arythmies cardiaques
SG200904004-9A SG153822A1 (en) 2004-06-15 2005-06-13 Novel oxabispidine compounds and their use in the treatment of cardiac arrhythmias
KR1020077000930A KR20070039045A (ko) 2004-06-15 2005-06-13 신규한 옥사비스피딘 화합물 및 이의 심부정맥의 치료에의용도
US11/570,451 US7648985B2 (en) 2004-06-15 2005-06-13 Oxabispidine compounds and their use in the treatment of cardiac arrhythmias
RU2006145202/04A RU2379311C9 (ru) 2004-06-15 2005-06-13 Новые оксабиспидиновые соединения и их применение в лечении сердечных аритмий
AU2005254924A AU2005254924B2 (en) 2004-06-15 2005-06-13 Novel oxabispidine compounds and their use in the treatment of cardiac arrhythmias
PCT/SE2005/000891 WO2005123748A1 (fr) 2004-06-15 2005-06-13 Nouveaux composes oxabispidine et leur utilisation dans le traitement des arythmies cardiaques
BRPI0512012-8A BRPI0512012A (pt) 2004-06-15 2005-06-13 composto ou um derivado farmaceuticamente aceitável do mesmo, formulação farmacêutica, uso de um composto, método de profilaxia ou tratamento de uma arritmia, e, processo para a preparação de um composto
CN200910134138A CN101525339A (zh) 2004-06-15 2005-06-13 新颖的氧杂双哌啶(oxabispidine)化合物以及它们在心律失常治疗中的应用
DK05752679.0T DK1765832T3 (da) 2004-06-15 2005-06-13 Hidtil ukendte oxabispidinforbindelser deres anvendelse til behandling af hjertearytmier
MXPA06014692A MXPA06014692A (es) 2004-06-15 2005-06-13 Nuevos compuestos de oxabispidina y su uso en el tratamiento de arritmias cardiacas.
CNA200580019259XA CN1968956A (zh) 2004-06-15 2005-06-13 新颖的氧杂双哌啶（oxabispidine）化合物以及它们在心律失常治疗中的应用
ES05752679T ES2434043T3 (es) 2004-06-15 2005-06-13 Compuestos de oxabispidina novedosos y su uso en el tratamiento de arritmias cardiacas
ARP050102431A AR049823A1 (es) 2004-06-15 2005-06-14 Compuestos de oxabispidina, proceso para obtenerlos, formulaciones farmaceuticas e intermediarios
UY28959A UY28959A1 (es) 2004-06-15 2005-06-14 Compuestos basados en bispidinas, 3,7-diazabiciclo (3,3,1)nonanos, particularmente oxabispidinas, sus sales y solvatos, composiciones conteniéndolos y procedimientos de preparación.
IL179560A IL179560A0 (en) 2004-06-15 2006-11-23 Novel oxabispidine compounds and their use in the treatment of cardiac arrhythmias
ZA200610418A ZA200610418B (en) 2004-06-15 2006-12-12 Novel oxabispidine compounds and their use in the treatment of cardiac arrhythmias
NO20070148A NO20070148L (no) 2004-06-15 2007-01-09 Nye oksabispidinforbindelser og deres anvendelse ved behandling av forstyrrelser i hjerterytmen
ZA200710111A ZA200710111B (en) 2004-06-15 2007-11-22 New oxabispidine compounds for the treatment of cardiac arrhythmias
US12/497,792 US20090270383A1 (en) 2004-06-15 2009-07-06 Novel Oxabispidine Compounds And Their Use In The Treatment Of Cardiac Arrhythmias
AU2009222548A AU2009222548A1 (en) 2004-06-15 2009-10-02 Novel oxabispidine compounds and their use in the treatment of cardiac arrhythmias

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0401539A SE0401539D0 (sv) 2004-06-15 2004-06-15 New compounds

Publications (1)

Publication Number Publication Date
SE0401539D0 true SE0401539D0 (sv) 2004-06-15

Family

ID=32710059

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0401539A SE0401539D0 (sv) 2004-06-15 2004-06-15 New compounds

Country Status (22)

Country Link
US (2) US7648985B2 (fr)
EP (1) EP1765832B8 (fr)
JP (1) JP2008502678A (fr)
KR (1) KR20070039045A (fr)
CN (2) CN1968956A (fr)
AR (1) AR049823A1 (fr)
AU (2) AU2005254924B2 (fr)
BR (1) BRPI0512012A (fr)
CA (1) CA2568895A1 (fr)
DK (1) DK1765832T3 (fr)
ES (1) ES2434043T3 (fr)
IL (1) IL179560A0 (fr)
MX (1) MXPA06014692A (fr)
NO (1) NO20070148L (fr)
RU (1) RU2379311C9 (fr)
SE (1) SE0401539D0 (fr)
SG (1) SG153822A1 (fr)
TW (1) TW200612907A (fr)
UA (1) UA85877C2 (fr)
UY (1) UY28959A1 (fr)
WO (1) WO2005123748A1 (fr)
ZA (2) ZA200610418B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0401539D0 (sv) 2004-06-15 2004-06-15 Astrazeneca Ab New compounds
CN101243093A (zh) 2005-06-13 2008-08-13 阿斯利康(瑞典)有限公司 用于治疗心律不齐的新型氧杂双哌啶化合物
TW200734342A (en) * 2005-12-15 2007-09-16 Astrazeneca Ab New compounds for the treatment of cardiac arrhythmias
MX2010013192A (es) 2008-06-16 2010-12-17 Hoffmann La Roche Monoamidas heteroaromaticas como antagonistas de receptor orexinina.
TW201004963A (en) * 2008-07-03 2010-02-01 Targacept Inc Derivatives of oxabispidine as neuronal nicotinic acetylcholine receptor ligands
WO2010059119A1 (fr) * 2008-11-21 2010-05-27 Astrazeneca Ab Combinaison de tert-butyl(2-{7-[2-(4-cyano-2-fluorophénoxy)éthyl]-9-oxa-3,7-diazabicyclo[3.3.1]non-3-yl}éthyl)carbamate et de certains benzofuranes antiarythmiques
US10077420B2 (en) 2014-12-02 2018-09-18 Histogenics Corporation Cell and tissue culture container
CN117384037B (zh) * 2023-12-13 2024-03-08 山东国邦药业有限公司 一种二氟乙酸乙酯的制备方法

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3196154A (en) * 1962-05-17 1965-07-20 Sterling Drug Inc 3-substituted-9-methyl-3, 9-diazabicyclo [3.3.1] nonanes
US3503939A (en) * 1967-03-29 1970-03-31 Du Pont Polyamides from heterocyclic diamines
CH488048A (de) 1969-06-12 1970-03-31 Inventa Ag Verfahren zur Herstellung von Polyesterfasern mit verbesserter Gummihaftung
DE2428792A1 (de) 1974-06-14 1976-01-02 Knoll Ag Neue antiarrhythmika
JPS5772977A (en) 1980-10-23 1982-05-07 Dainippon Ink & Chem Inc Fluorine-containing diepoxy compound and its preparation
DE3112055A1 (de) 1981-03-27 1982-10-07 Basf Ag, 6700 Ludwigshafen Bispidinderivate, ihre herstellung und diese enthaltende arzneimittel
DE3234697A1 (de) 1982-09-18 1984-03-22 Kali-Chemie Pharma Gmbh, 3000 Hannover Neue diazabicyclo-(3,3,1)-nonane
US4533713A (en) * 1983-05-06 1985-08-06 Minnesota Mining And Manufacturing Company Fluoroaliphaticsulfonamides containing oxirane groups and/or N-β-hydroxyalkylene groups
PT88381B (pt) 1987-09-09 1995-07-06 Kali Chemie Pharma Gmbh Processo para a preparacao de novos compostos 3,7-diazabiciclo{3,3,1} nonano, e de composicoes farmaceuticas que contem estes compostos
DE3732094A1 (de) 1987-09-24 1989-04-06 Basf Ag Bispidinderivate als klasse iii-antiarrhythmika
US5140033A (en) * 1989-04-03 1992-08-18 Bayer Aktiengesellschaft Antibacterial 5-alkylquinolonecarboxylic acids
US5110933A (en) 1989-11-13 1992-05-05 Board Of Regents Of Oklahoma State University Salts of 3-azabicyclo[3.3.1]nonanes as antiarrhythmic agents, and precursors thereof
IL96507A0 (en) * 1989-12-08 1991-08-16 Merck & Co Inc Nitrogen-containing spirocycles and pharmaceutical compositions containing them
FI100151B (fi) 1992-09-04 1997-09-30 Nokia Mobile Phones Ltd Tehonsäästö matkaviestimessä
US5294621A (en) * 1992-10-07 1994-03-15 Ortho Pharmaceutical Corporation Thieno tetrahydropyridines useful as class III antiarrhythmic agents
JPH06284071A (ja) 1993-01-27 1994-10-07 Casio Comput Co Ltd 無線受信機
US5468858A (en) 1993-10-28 1995-11-21 The Board Of Regents Of Oklahoma State University Physical Sciences N-alkyl and n-acyl derivatives of 3,7-diazabicyclo-[3.3.1]nonanes and selected salts thereof as multi-class antiarrhythmic agents
FR2713081B1 (fr) 1993-11-29 1996-01-12 Celsa Lg Filtre sanguin perfectionné à deux séries de pattes en pétales.
US5831099A (en) * 1995-03-10 1998-11-03 The United States Of America As Represented By The Secretary Of The Army Compounds of 1,5-disubstituted-3,7 diaza bicyclo 3.3.0! octanes and products containing the same
SE9704709D0 (sv) 1997-12-17 1997-12-17 Astra Ab Pharmaceutically active compounds
CN1147483C (zh) 1999-04-09 2004-04-28 阿斯特拉曾尼卡有限公司 金刚烷衍生物
SE9903759D0 (sv) 1999-10-18 1999-10-18 Astra Ab Pharmaceutically active compounds
AR030756A1 (es) * 2000-10-02 2003-09-03 Astrazeneca Ab Compuesto de oxabispidina util en el tratamiento de arritmias cardiacas
SE0101327D0 (sv) * 2001-04-12 2001-04-12 Astrazeneca Ab New crystalline forms
SE0101323D0 (sv) 2001-04-12 2001-04-12 Astrazeneca Ab New process
SE0101324D0 (sv) * 2001-04-12 2001-04-12 Astrazeneca Ab New process
SE0201662D0 (sv) 2002-05-31 2002-05-31 Astrazeneca Ab Pharmaceutical combination
GB0223712D0 (en) 2002-10-14 2002-11-20 Astrazeneca Ab Chemical intermediate
SE0401539D0 (sv) 2004-06-15 2004-06-15 Astrazeneca Ab New compounds
SE0401540D0 (sv) * 2004-06-15 2004-06-15 Astrazeneca Ab New compounds

Also Published As

Publication number Publication date
CA2568895A1 (fr) 2005-12-29
ES2434043T3 (es) 2013-12-13
EP1765832A1 (fr) 2007-03-28
KR20070039045A (ko) 2007-04-11
US20090005558A1 (en) 2009-01-01
AU2009222548A1 (en) 2009-10-22
IL179560A0 (en) 2007-05-15
AR049823A1 (es) 2006-09-06
AU2005254924A1 (en) 2005-12-29
AU2005254924B2 (en) 2009-08-27
US20090270383A1 (en) 2009-10-29
RU2379311C9 (ru) 2010-05-27
US7648985B2 (en) 2010-01-19
TW200612907A (en) 2006-05-01
WO2005123748A1 (fr) 2005-12-29
JP2008502678A (ja) 2008-01-31
EP1765832B1 (fr) 2013-08-14
BRPI0512012A (pt) 2008-02-06
UY28959A1 (es) 2006-01-31
UA85877C2 (uk) 2009-03-10
CN1968956A (zh) 2007-05-23
MXPA06014692A (es) 2007-02-12
DK1765832T3 (da) 2013-10-21
ZA200610418B (en) 2008-07-30
ZA200710111B (en) 2009-08-26
EP1765832B8 (fr) 2013-09-25
SG153822A1 (en) 2009-07-29
CN101525339A (zh) 2009-09-09
NO20070148L (no) 2007-01-09
RU2006145202A (ru) 2008-07-20
RU2379311C2 (ru) 2010-01-20

Similar Documents

Publication Publication Date Title
AP1536A (en) New oxabispidine compounds useful in the treatment of cardiac arrhythmias.
NO20062950L (no) 5,7-diaminopyrazolo `43-Dlpyrimidiner med PDE-5 inhiberende aktivitet
MX2009000420A (es) Derivados de isoindolina para el tratamiento de arritmias.
WO2004048335A3 (fr) Derives d'acide mandelique
MY142768A (en) Gfat inhibitors
MX2010013602A (es) Compuesto heterociclico y uso del mismo.
TW200745004A (en) Novel compounds, their preparation and use
EA200600223A1 (ru) Замещённый 2-аминотетралины для лечения депрессии
MX2007013203A (es) Nuevas aminas ciclicas.
TW200745032A (en) Novel heterobicyclic derivatives
SE0401970D0 (sv) Novel compounds
EA200801607A1 (ru) Производные бензимидазолонкарбоновой кислоты
NO20070089L (no) DPP-IV inhibitorer
SE0100326D0 (sv) New compounds
TW200738692A (en) New substituted glycinamides, process for their manufacture and use thereof as medicaments
NO20070148L (no) Nye oksabispidinforbindelser og deres anvendelse ved behandling av forstyrrelser i hjerterytmen
TW200734342A (en) New compounds for the treatment of cardiac arrhythmias
NO20070147L (no) Nye oksabispidinforbindelser og deres anvendelse ved behandling av forstyrrelser i hjerterytmen
MX2009013003A (es) Derivados de piperidina-amida.
ECSP078025A (es) Nuevos compuestos de oxabispidina para el tratamiento de las arritmias cardíacas
SE0003795D0 (sv) Pharmaceutically useful compounds
MX2008001778A (es) Combinacion de un agente hipnotico y un compuesto de bis arilo y heteroarilo sustituido y aplicacion terapeutica de la misma.
UA86873C2 (en) SUBSTITUTED ARYL 1,4-PYRAZlNE DERIVATIVES
TW200738736A (en) New compounds for the treatment of cardiac arrhythmias
NO20062307L (no) Spirofuropyridinarylderivater